Tarsus Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.76 M | $123.52 M | 100.00% | 9.78% |
RTW INVESTMENTS, LP | 11/14/2024 | 3.41 M | $112.24 M | 0.00% | 8.89% |
PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2024 | 2.44 M | $80.27 M | 0.21% | 6.36% |
TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 2.25 M | $74.16 M | 0.00% | 5.87% |
MORGAN STANLEY | 11/14/2024 | 2.21 M | $72.64 M | 17.19% | 5.75% |
COWEN AND COMPANY, LLC | 11/12/2024 | 2.20 M | $72.27 M | 0.00% | 5.73% |
JENNISON ASSOCIATES LLC | 11/08/2024 | 2.18 M | $71.65 M | 47.21% | 5.68% |
VANGUARD GROUP INC | 11/13/2024 | 2.10 M | $68.98 M | 5.41% | 5.46% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 1.59 M | $52.21 M | 0.00% | 4.14% |
PERCEPTIVE ADVISORS LLC | 11/14/2024 | 1.30 M | $42.64 M | 0.00% | 3.38% |
ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 1.14 M | $37.54 M | 7.32% | 2.97% |
IKARIAN CAPITAL, LLC | 11/14/2024 | 1.03 M | $33.89 M | 28.74% | 2.68% |
STATE STREET CORP | 11/14/2024 | 899,379 | $29.58 M | -2.84% | 2.34% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 883,043 | $29.04 M | 31.71% | 2.30% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 835,790 | $27.49 M | 8.09% | 2.18% |
ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2024 | 709,018 | $23.32 M | 12.98% | 1.85% |
INVESCO LTD. | 11/12/2024 | 682,097 | $22.43 M | 74.20% | 1.78% |
TFG ASSET MANAGEMENT GP LTD | 11/14/2024 | 614,117 | $20.20 M | 22.82% | 1.60% |
MACQUARIE GROUP LTD | 11/14/2024 | 594,878 | $19.57 M | 30.75% | 1.55% |
LORD, ABBETT & CO. LLC | 12/13/2024 | 594,876 | $19.57 M | 28.42% | 1.55% |
ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 587,030 | $19.31 M | -1.23% | 1.53% |
J. GOLDMAN & CO LP | 11/14/2024 | 557,500 | $18.34 M | 44.00% | 1.45% |
CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 500,000 | $16.45 M | 0.00% | 1.30% |
JPMORGAN CHASE & CO | 12/26/2024 | 440,167 | $14.48 M | 2,088.80% | 1.15% |
JEFFERIES FINANCIAL GROUP INC. | 11/14/2024 | 420,758 | $13.84 M | 0.00% | 1.10% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 403,963 | $13.29 M | -0.72% | 1.05% |
CITADEL ADVISORS LLC | 11/14/2024 | 384,467 | $12.65 M | 85.30% | 1.00% |
INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 375,000 | $12.33 M | -36.44% | 0.98% |
GHOST TREE CAPITAL, LLC | 11/14/2024 | 350,000 | $11.51 M | 48.94% | 0.91% |
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 11/13/2024 | 338,400 | $11.13 M | -13.14% | 0.88% |
ALLY BRIDGE GROUP (NY) LLC | 11/14/2024 | 321,898 | $10.59 M | 100.00% | 0.84% |
NORTHERN TRUST CORP | 11/13/2024 | 317,555 | $10.44 M | 25.51% | 0.83% |
CAPTION MANAGEMENT, LLC | 11/14/2024 | 300,100 | $9.87 M | 100.00% | 0.78% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 296,003 | $9.74 M | -31.85% | 0.77% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 290,009 | $9.54 M | 10.74% | 0.76% |
BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 275,563 | $9.06 M | 37.72% | 0.72% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 268,775 | $8.84 M | 30.76% | 0.70% |
TWO SIGMA ADVISERS, LP | 11/14/2024 | 256,400 | $8.43 M | -16.65% | 0.67% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 239,315 | $7.87 M | -17.84% | 0.62% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 233,468 | $7.68 M | -3.97% | 0.61% |
TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 231,820 | $7.62 M | -58.33% | 0.60% |
VESTAL POINT CAPITAL, LP | 11/14/2024 | 230,000 | $7.56 M | 100.00% | 0.60% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 222,515 | $7.32 M | -36.17% | 0.58% |
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 10/18/2024 | 210,531 | $6.92 M | 16.27% | 0.55% |
AIGH CAPITAL MANAGEMENT LLC | 11/13/2024 | 204,413 | $6.72 M | 100.00% | 0.53% |
CLEARBRIDGE INVESTMENTS, LLC | 11/12/2024 | 191,374 | $6.29 M | 100.00% | 0.50% |
SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 187,513 | $6.17 M | 566.43% | 0.49% |
D. E. SHAW & CO., INC. | 11/14/2024 | 182,095 | $5.99 M | -32.51% | 0.47% |
SANDS CAPITAL VENTURES, LLC | 11/13/2024 | 170,000 | $5.59 M | 0.00% | 0.44% |
BAIRD FINANCIAL GROUP, INC. | 11/14/2024 | 146,436 | $4.82 M | 18.31% | 0.38% |
Tarsus Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 179 institutional investors and hedge funds held shares of Tarsus Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 3.76 M
RTW INVESTMENTS, LP: 3.41 M
Paradigm Biocapital Advisors LP: 2.44 M
TANG CAPITAL MANAGEMENT LLC: 2.25 M
MORGAN STANLEY: 2.21 M
COWEN AND COMPANY, LLC: 2.2 M
113.06% of Tarsus Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 45.29 M shares in the last 24 months. This purchase volume represents approximately $2.24 B in transactions.